Sunday 21 January 2018 ShareProphets: The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

My Top 10 stocks to buy on AIM (to dodge IHT) – Tom Winnifrith

By Tom Winnifrith | Sunday 13 September 2015

Disclosure: Financial Investigative Media Limited, which is not owned by Tom Winnifrith but by a trust for his dependants, owns shares in companies mentioned in this article. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

It is all very well to ridicule the Daily Telegraph’s top ten AIM shares to buy to dodge IHT as I did yesterday HERE but could you do any better asks a reader. Possibly not, I don’t really like the AIM Casino but I am always up for a challenge so here goes.

The list below is my basket of ten – I hot link each one to our coverage here on ShareProphets which is in some cases fuller than other. Three are in there since we own them and thus it would be odd for me not to include them ( that is 1-3). The others are there with capital preservation (this is IHT dodging we are talking about) in mind although I hope for dividends and growth from the lot.

1. Optibiotix (OPTI)
2. Premaitha (NIPT)
3. React (REAT)
4. New World Oil & Gas (NEW) – I am not joking.
5. Stanley Gibbons (SGI)
6. Interquest (ITQ)
7. IS Solutions (ISL)
8. GLI Finance (GLIF)
9. Plastics Capital (PLA)
10. Adept Telecom (ADT)

Let’s see how both portfolios have fared in a few years time.

One of the ten in my selection is included in the book that myself and the ShareProphets team published last week, The Magnificent Seven Shares to buy after the stockmarket crash. To order your free copy go HERE

Filed under:

Never miss a story.

This area of the site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.

More on OPTI


Enter your comment below. Fields marked * are required. You must preview your comment first before finally posting.

Site by Everywhen